Article
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.
Blood - 1 Dec 2005
Gale Rosemary E, Hills Robert, Pizzey Arnold R, Kottaridis Panagiotis D, Swirsky David, Gilkes Amanda F, Nugent Elizabeth, Mills Kenneth I, Wheatley Keith, Solomon Ellen, Burnett Alan K, Linch David C, Grimwade David
Abstract excerpt
The prognostic significance of FLT3 mutations in acute promyelocytic leukemia (APL) is not firmly established and is of particular interest given the opportunities for targeted therapies using FLT3 inhibitors. We studied 203 patients with PML-RARA-positive APL; 43% of the patients had an FLT3 mutation (65 internal tandem duplications [ITDs], 19 D835/I836, 4 ITD+D835/I836). Both mutations were associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
